BRCA1/2 MUTATION OR NOT

Clinical trials for BRCA1/2 MUTATION OR NOT explained in plain language.

Never miss a new study

Get alerted when new BRCA1/2 MUTATION OR NOT trials appear

Sign up with your email to follow new studies for BRCA1/2 MUTATION OR NOT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug trial aims to keep aggressive breast cancer at bay

Disease control Not yet recruiting

This study tests whether a drug called fluzoparib can help control advanced triple-negative breast cancer after initial treatment. It will involve 72 patients whose cancer responded to platinum-based chemotherapy but could still return. The goal is to see if taking fluzoparib as …

Matched conditions: BRCA1/2 MUTATION OR NOT

Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

BRCA1/2 MUTATION OR NOT

Get alerted when new BRCA1/2 MUTATION OR NOT trials appear

New drug trial aims to keep aggressive breast cancer at bay